Phase
Condition
Thrombosis
Dysfunctional Uterine Bleeding
Immune (Idiopathic) Thrombocytopenic Purpura (Itp)
Treatment
IVIg
Prednisone
Clinical Study ID
Ages 18-50 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18-50 years old;
Meet the diagnostic criteria for immune thrombocytopenia;
Pregnant women with ITP without ITP-specific treatments during pregnancy;
Gestational weeks ≥12 weeks;
Platelet count <30×10^9/L, accompanied with or without bleeding symptoms.
Willing and able to sign written informed consent.
Exclusion
Exclusion Criteria:
Have a known diagnosis of other autoimmune diseases, confirmed medical history orlaboratory findings within positive anti-nuclear antibodies (>1:80),anti-cardiolipin antibodies, lupus anticoagulant factors or direct Coombs' test.
Thrombocytopenia caused by pregnancy-specific conditions, such as gestationalthrombocytopenia, preeclampsia, the HELLP syndrome and acute fatty liver ofpregnancy.
Secondary thrombocytopenia such as drug-related thrombocytopenia, vaccine-relatedthrombocytopenia, lymphoproliferative disorders, severe infection, hepatic cirrhosisand so on.
With other underlying diseases that may cause thrombocytopenia, such as: malignantdisease, megaloblastic anemia, aplastic anemia, myelodysplasia syndrome, myeloidfibrosis, disseminated intravascular coagulation, thrombotic thrombocytopenicpurpura, Hemolytic uremic syndrome, disseminated intravascular coagulation and soon;
Current HIV infection or hepatitis B virus or hepatitis C virus infections;
With severe heart, kidney, liver or respiratory dysfunction;
With the medical history of mental illness;
Have allergic reaction to prednisone or IVIg;
Study Design
Study Description
Connect with a study center
Peking University Insititute of Hematology, Peking University People's Hospital
Beijing, Beijing 100010
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.